Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Mar;20(119):3-6.
doi: 10.1183/09059180.00000311.

Milestones in lymphangioleiomyomatosis research

V Cottin, F Archer, C Leroux, J-F Mornex, J-F Cordier
Editorial

Milestones in lymphangioleiomyomatosis research

V Cottin et al. Eur Respir Rev. 2011 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Statement of Interest

V. Cottin and J.F. Cordier have participated as investigators in clinical trials sponsored by Novartis. V. Cottin has served on an advisory board for Novartis. J-F. Cordier has received consulting fees, speaking fees and/or honoraria from Pfizer, GlaxoSmithKline and Actelion.

Comment on

References

    1. Johnson SR. Lymphangioleiomyomatosis. Eur Respir J 2006; 27: 1056–1065. - PubMed
    1. Harari S, Caminati A. Update on diffuse parenchymal lung disease. Eur Respir Rev 2010; 19: 97–108. - PMC - PubMed
    1. Cordier JF, Lazor R. Perspectives on lymphangioleiomyomatosis in France. In: Moss J, ed. Lymphangioleiomyomatosis and Other Diseases Characterized by Smooth Muscle Proliferation. New York, Marcel Dekker, 1998: pp. 9–31.
    1. Moss J, Avila NA, Barnes PM, et al. . Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001; 164: 669–671. - PubMed
    1. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991; 615: 125–127. - PubMed

MeSH terms

LinkOut - more resources